To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Fatigue|Locally Advanced or Metastatic Breast Cancer
Interventions: DRUG: Reparixin|DRUG: Placebo
Sponsor: Dompé Farmaceutici S.p.A